Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease.
Markov NS, Esposito AJ, Senkow KJ, Schleck M, Cusick L, Yu Z, Sokolenko YV, Diaz E, Jonasson E, Swaminathan S, Lu Z, Nafikova R, Fenske S, Bunyan EG, Pérez-Leonor XG, Abdala-Valencia H, Flozak AS, Joshi N, Argento AC, Malsin ES, Reyfman PA, Puchalski J, Gulati M, Carns M, Aren K, Cooper P, Field NS, Mohsin S, Shawabkeh M, Soriano A, Gundersheimer AN, Goldberg IA, Damore B, Peltekian A, Agrawal A, Cheung C, Perez S, Teaw S, Williams A, Page N, Kujawski SE, Odell W, Gunes BI, Cheng M, Emokpae M, Cumming RI, Tighe RM, Grudzinski K, Savas H, Rubinowitz AN, Kadhim BA, Kurihara C, Bharat A, Mehta V, Dematte JE, Bemiss BC, Makinde HM, Cuda CM, Dapas M, Richardson C, Perlman H, Lam AP, Gottardi CJ, Budinger GRS, Misharin AV, Hinchcliff ME.
Markov NS, et al. Among authors: teaw s.
bioRxiv [Preprint]. 2025 Oct 8:2025.08.07.669006. doi: 10.1101/2025.08.07.669006.
bioRxiv. 2025.
PMID: 40832362
Free PMC article.
Preprint.
